Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-206344

President & CEO sold 5,467 shares at $18.92 ($103,447)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Warmuth Markus · President & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-01 Sale : show line 1 in the form 10b5-1 −5,467 $18.92 $103,447 600,004 D
Open-market sales · 5,467 sh · avg $18.92 · $103,447
Loading xslF345X06/ownership.xml…